ADX-629 (Open-label)

Drug identity checked against registry records

Also recorded as ADX-629; Open-label

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)NCT05717920ALDXPhase 2Completed2023-11-21Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.